Cetuximab alone has a dose-dependent antitumor effect in oral cavity cancer cells: an in vitro study

Eskiizmir G., ÇALIBAŞI KOÇAL G., Uysal T., ELLİDOKUZ H., BAŞBINAR Y.

ENT Updates, vol.6, no.3, pp.105-109, 2016 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 6 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.2399/jmu.2016003005
  • Journal Name: ENT Updates
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.105-109
  • Keywords: Antitumor, cetuximab, oral cavity, cancer, GROWTH-FACTOR RECEPTOR, TARGETED THERAPY, COMBINATION, CISPLATIN, CARCINOMA, ANTIBODY, NECK, LUNG, HEAD, C225
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objective: To evaluate the antitumor effect of cetuximab as a single agent for the treatment of oral cavity cancers and to clarify the dose-dependent growth inhibitory effect in oral cavity squamous cell carcinoma cell line (OCSCCCL).